# IQVIA

- Status: Unclaimed: compiled by Nowen from public sources, not reviewed by the company
- Industry: Contract Research Organizations
- Market category: AI Agent Platforms (https://nowen.ai/category/ai-agent-platforms)
- Delivery model: hybrid
- Website: https://iqvia.com
- Legal name: IQVIA Holdings Inc.
- AI agent profile: https://nowen.ai/agents/iqvia-com
- Front door on Boon: https://boon.ai/agents/iqvia-com (Apply to IQVIA's partner program through Boon)
- Updated: 2026-11-04
- Directory: one of 4 AI agents in Contract Research Organizations (https://nowen.ai/industry/contract-research-organizations); one of 89 AI agents in AI Agent Platforms (https://nowen.ai/category/ai-agent-platforms)
- Read by AI assistants from: OpenAI, Perplexity, Meta, Amazon

> IQVIA provides healthcare intelligence, clinical research services, commercial insights, and technology to life sciences and healthcare organizations.

IQVIA provides clinical research services, commercial insights, healthcare intelligence, data, analytics, technology, and expertise to life sciences and healthcare organizations. It supports research and development, evidence generation, commercialization, and healthcare decision-making, with a focus on responsible AI, privacy, regulatory compliance, and improving patient outcomes.

**Mission:** To accelerate the development and commercialization of innovative medical treatments and help improve patient outcomes and population health worldwide.

## Products & Services

### [IQVIA Life Science Models](https://www.iqvia.com/solutions/innovative-models/artificial-intelligence-and-machine-learning/life-science-models)
*Product*
Simulate patient, clinical trial and market outcomes to test decisions, choose stronger options and avoid costly rework.
IQVIA Life Science Models combine longitudinal patient data, biomedical knowledge and predictive AI to simulate outcomes across patients, clinical trials and markets. Life sciences teams can test clinical and commercial decisions before making them, helping them choose stronger options, avoid costly rework and move forward with confidence.

- **Clinical trial simulation** — Test Clinical Study Decisions
- **Patient outcome simulation** — Simulate Patient Outcomes
- **Market simulation** — Evaluate Market Decisions
- **Predictive modeling foundation** — Combine Data, Knowledge, And AI

### [Predictive Clinical Development](https://www.iqvia.com/solutions/research-and-development)
*Solution*
Identify development risks earlier, prevent delays and make faster decisions to accelerate clinical development planning and delivery.
Predictive Clinical Development helps identify and address development risks early to prevent delays and accelerate clinical development planning and delivery. It brings AI and clinical development expertise together with connected data, technology and analytics to optimize trials, support faster decision-making and reduce risk.

- **Early risk identification** — Identify Risks Earlier
- **Development cycle acceleration** — Accelerate Development Delivery
- **Delay prevention** — Prevent Development Delays
- **Connected data, technology and analytics** — Connect Data And Analytics

### [IQVIA.ai](https://www.iqvia.com/solutions/innovative-models/artificial-intelligence-and-machine-learning/iqvia-ai-platform)
*Platform*
IQVIA.ai helps life sciences organizations streamline workflows, accelerate research and analysis, and make more confident, timely decisions.
IQVIA.ai is a unified agentic AI platform purpose-built for life sciences. It combines conversational AI with ready-to-use and configurable intelligent agents, AI-driven workflow automation, advanced analytics and decision support. The platform coordinates tasks and insights across data sources and functions, supporting clinical, commercial and real-world workflows. It is designed to operate securely and in alignment with healthcare regulatory, privacy and quality standards.
- Categories: AI Agent Platforms (https://nowen.ai/category/ai-agent-platforms)

- **Responsible, regulated AI operations** — Scale AI Within Healthcare Standards
- **Intelligent agent catalog** — Deploy Agents For Life Sciences Workflows
- **AI-driven workflow automation** — Automate And Streamline Complex Operations
- **Cross-domain workflow orchestration** — Coordinate Tasks Across Data And Functions
- **Conversational AI** — Research And Generate Through One Conversation
- **Advanced analytics** — Analyze Data For Actionable Insights
- **Decision support** — Support Timely, Confident Decisions
- **Operational feedback learning** — Learn From Operational Feedback

### [IQVIA Field Force Agent](https://www.iqvia.com/solutions/commercialization/commercial-analytics/omnichannel-engagement-and-insights/field-force-agent)
*Product*
Helps life sciences field teams plan and deliver higher-impact, compliant HCP engagements with real-time insights and curated healthcare data.
IQVIA Field Force Agent is an AI-powered assistant that helps life sciences field teams plan and execute high-impact, compliant HCP engagements. It delivers real-time insights using IQVIA’s curated, agent-ready healthcare data, including IQVIA OneKey, to support smarter segmentation, dynamic targeting, and deeper HCP and HCO profiling.

- **Compliant HCP engagement planning and execution** — Plan Compliant HCP Engagements
- **AI-powered field team assistance** — Support Field Team Work
- **Real-time field insights** — Guide Engagements With Insights
- **Curated agent-ready healthcare data** — Ground Decisions In Curated Data
- **HCP segmentation** — Segment HCPs More Effectively
- **Dynamic HCP targeting** — Target HCPs Dynamically
- **HCP and HCO profiling** — Deepen HCP And HCO Profiles

### [IQVIA Global Market Insights Agent](https://www.iqvia.com/)
*Product*
Connects global market intelligence to help customers understand market shifts, refine launch strategies and identify emerging opportunities.
IQVIA Global Market Insights (GMI) Agent uses agentic AI to provide a unified view of the global market landscape and answer multidimensional questions. It analyzes market shifts using real-time HCP sentiment, supports launch strategy optimization with competitive intelligence, identifies trends across sales, promotional channels and physician engagement, and provides forward-looking insights through pipeline analysis and loss-of-protection timelines.

- **Unified global market analysis** — Unify Global Market Insights
- **Real-time HCP sentiment analysis** — Track Market Shifts
- **Competitive launch intelligence** — Refine Launch Strategies
- **Sales trend identification** — Identify Sales Trends
- **Promotional channel trend identification** — Identify Channel Trends
- **Physician engagement trend identification** — Identify Engagement Trends
- **Pipeline analysis** — Assess Pipeline Insights
- **Loss-of-protection timeline insights** — Review Protection Timelines

### [IQVIA Explorer](https://www.iqvia.com/newsroom/2026/10/iqvia-launches-iqvia-explorer-to-help-life-sciences-companies-make-better-commercial-decisions)
*Product*
Helps life sciences companies make better commercial decisions.
IQVIA Explorer is a commercial decision-support product announced by IQVIA to help life sciences companies make better commercial decisions.

### [IQVIA Commercial Agentic AI](https://www.iqvia.com/solutions/commercialization/iqvia-commercial-agentic-ai)
*Solution*
Helps commercial teams improve precision, speed and business impact across workflows and customer journey activities.
IQVIA Commercial Agentic AI provides AI agents designed specifically for commercial teams, supporting planning, engagement and execution across the customer journey. It helps enhance precision, speed and business impact across commercial workflows.
- Categories: AI Agent Platforms (https://nowen.ai/category/ai-agent-platforms)

- **Commercial workflow agents** — Improve Workflow Precision And Speed
- **Customer journey support** — Support Planning Engagement And Execution

### [IQVIA Literature AI Platform](https://www.iqvia.com/blogs/2026/06/iqvia-literature-ai-platform-for-scientific-literature-reviews)
*Platform*
Accelerates scientific literature reviews while reducing screening effort and producing rigorous, traceable outputs.
An agentic system built specifically for scientific literature review. It accelerates the process from search to synthesis while delivering rigorous, traceable outputs aligned with established quality standards.

- **Scientific literature search** — Find Relevant Literature
- **Document screening** — Screen Documents Precisely
- **Screening workload reduction** — Reduce Screening Workload
- **Literature synthesis** — Accelerate Literature Synthesis
- **Traceable review outputs** — Produce Traceable Outputs

### [IQVIA Privacy Analytics Platform](https://www.iqvia.com/blogs/2026/06/paving-the-way-for-scalable-data-privacy-and-real-world-impact)
*Platform*
Enables health data use while helping protect individual privacy, including through deployment within England's NHS Federated Data Platform.
A platform that enables privacy-preserving use of data, including deployment within England's NHS Federated Data Platform.

- **Privacy-preserving data use** — Enable Privacy-Preserving Data Use
- **Federated health data deployment** — Deploy Within Federated Health Data Infrastructure

### [IQVIA SmartSolve RIM](https://www.iqvia.com/blogs/2026/04/iqvia-smartsolve-rim-wins-silver-stevie-award-for-healthcare-technology-innovation)
*Platform*
Supports regulatory compliance and global approvals to help enable timely access to healthcare products.
IQVIA SmartSolve RIM is an AI-enabled regulatory information management platform that supports global regulatory approvals, compliance, and timely access to healthcare products.

- **Regulatory information management** — Manage Regulatory Information
- **Regulatory approval support** — Support Global Approvals
- **Compliance support** — Strengthen Regulatory Compliance

### [IQVIA IRT Supply Automation Value Engine (SAVE)](https://www.iqvia.com/blogs/2026/05/iqvia-irt-save-recognized-with-silver-stevie-award-for-innovation-in-clinical-supply-management)
*Solution*
Optimizes clinical trial medicine supply to sites with real-time analytics and automation, helping reduce deliveries and site stockouts.
A clinical trial supply program that uses real-time analytics and automation to optimize the supply of trial medicines to sites, reduce deliveries, and help prevent sites from running out of needed medicines.

- **Real-time supply analytics** — Monitor And Optimize Supply
- **Delivery reduction** — Reduce Drug Supply Deliveries
- **Site stockout reduction** — Reduce Site Medicine Stockouts
- **Clinical supply automation** — Automate Clinical Supply Management

### [AI-enabled clinical decision support tool for type 1 diabetes](https://www.iqvia.com/newsroom/2026/08/iqvia-ai-enabled-clinical-decision-support-tool-wins-2026-ai-breakthrough-award)
*Product*
Helps identify patients who may have misdiagnosed or misclassified type 1 diabetes while reducing screening burden.
An AI-enabled clinical decision support tool developed in collaboration with Breakthrough T1D to identify patients who may have misdiagnosed or misclassified type 1 diabetes.

- **Patient identification** — Identify Potentially Misdiagnosed Patients
- **Screening burden reduction** — Reduce Screening Burden

### [IQVIA Emerging Biopharma Commercial Solutions](https://www.iqvia.com/solutions/industry-segments/emerging-biopharma)
*Solution*
Helps emerging biopharma organizations advance commercialization, improve market access and stakeholder engagement, and maximize asset value from prioritization through growth.
A dedicated IQVIA offering for emerging biopharma organizations, combining integrated data, expertise and purpose-built teams to support the journey from market prioritization through execution and from launch through growth. Its Asset Maximizer Commercial Success Framework provides an end-to-end commercialization roadmap to strengthen asset value, access, adoption and execution. The offering supports differentiation, stakeholder engagement, connected intelligence and operational excellence.

- **End-to-end commercialization roadmap** — Guide Asset Commercialization
- **Integrated lifecycle execution** — Coordinate Lifecycle Execution
- **Evidence-based differentiation strategy** — Differentiate Asset Value
- **Market access and adoption planning** — Advance Market Access
- **Connected commercial intelligence** — Uncover Commercial Opportunities
- **Personalized omnichannel engagement** — Personalize Stakeholder Engagement
- **Operational commercialization excellence** — Scale Commercial Operations
- **Commercial model build and launch deployment** — Build Launch Capabilities

### [Research & Development Solutions](https://www.iqvia.com/solutions/research-and-development)
*Solution*
Optimize clinical trials, reduce risk and support faster delivery of life-changing therapies with connected data, technology, analytics and R&D services.
IQVIA’s Research & Development solutions connect data, technology and analytics to optimize clinical trials, support faster decision-making and reduce risk. The offering spans early-phase and Phase IIb/III trials, patient- and site-centric tools and services, functional trial services, specialty and central laboratories, and R&D consulting. It also includes clinical development services for biotechnology companies delivered by specialized, dedicated teams, with therapeutically aligned support, patient and site services, laboratories and R&D consulting.

- **Clinical trial optimization** — Optimize Trials And Reduce Risk
- **Dedicated, therapeutically aligned clinical development teams** — Advance Programs To Milestones
- **Early-phase clinical development** — Establish Proof Of Concept Faster
- **Phase IIb/III trial support** — Navigate Complex Later-Phase Trials
- **Patient and site trial support** — Improve Recruitment And Study Execution
- **Agile functional trial services** — Connect Trial Delivery
- **R&D strategy consulting** — Optimize R&D Strategy
- **Specialty and central laboratory services** — Access Specialized Lab Expertise

### [Real World Evidence solutions](https://www.iqvia.com/solutions/real-world-evidence)
*Service*
Turn real-world information into evidence that supports smarter decisions and helps address clinical, regulatory and commercial questions.
IQVIA generates and disseminates real-world evidence to address clinical, regulatory and commercial questions and support informed decisions. Its solutions include real-world and healthcare data, study design, evidence networks, health economics and value, and regulatory and safety support. IQVIA also draws on information from past trials, patient-reported outcomes and other sources to support research and evidence generation across the product lifecycle.

- **Evidence generation for stakeholder decisions** — Answer Critical Questions With Evidence
- **Real-world and healthcare data** — Explore Data For Lifecycle Insights
- **Study design** — Design Studies With Emerging Evidence Methods
- **Evidence networks** — Enrich Studies Through Evidence Networks
- **Health economics and value** — Demonstrate Product Value With Clearer Evidence
- **Regulatory and safety support** — Address Regulatory And Safety Needs

### [Commercialization solutions](https://www.iqvia.com/solutions/commercialization)
*Solution*
Improve commercial decisions, strengthen engagement and support brand growth with data, analytics, technology and expertise.
IQVIA's commercialization solutions combine data, analytics, technology and domain expertise to help organizations transform market strategy and execute precisely. The offering includes brand and portfolio strategy, launch management, commercial analytics, data and information management, HCP and patient engagement, omnichannel communications, pricing and market access, and optimization for established brands. Scalable resources and analytics powered by machine learning and artificial intelligence support commercial effectiveness across the product lifecycle.

- **Commercial analytics** — Improve Commercial Decisions
- **Launch strategy and management** — Strengthen Product Launches
- **Brand and portfolio strategy** — Shape Brand Strategy
- **Data and information management** — Use Quality Data
- **Artificial intelligence and machine learning** — Apply AI-Powered Analytics
- **HCP engagement** — Engage Healthcare Professionals
- **Patient engagement and support** — Support Patient Engagement
- **Pricing and market access** — Support Market Access
- **Established brand optimization** — Defend Brand Market Share
- **Omnichannel engagement** — Personalize Cross-Channel Communications

### [Safety and regulatory compliance solutions](https://www.iqvia.com/solutions/safety-regulatory-compliance)
*Solution*
Streamline safety and compliance work, manage regulatory requirements, and address changing stakeholder demands and cost constraints.
IQVIA combines technology, services and analytics-driven offerings to help organizations address changing stakeholder demands and cost constraints across safety, regulatory, quality and commercial compliance. The solutions include automated drug safety and pharmacovigilance, regulatory management, enterprise quality management, and processes for compliance with global engagement and transparency regulations and codes.

- **Drug safety and pharmacovigilance** — Streamline Safety Work And Reduce Costs
- **Regulatory compliance management** — Automate And Standardize Regulatory Management
- **Quality compliance management** — Manage Quality Across Your Organization
- **Commercial compliance** — Manage Global Engagement And Transparency Compliance

### [IQVIA Technologies](https://www.iqvia.com/solutions/technologies)
*Service*
Use AI-driven technology and analytics to support greater efficiency and generate business insights without additional capital investment.
IQVIA Technologies combines data science, technology and analytics driven by artificial intelligence to support new efficiencies and business insights. The offering is designed to provide these capabilities without additional capital investment.

- **AI-driven data and analytics capabilities** — Combine Data Science, Technology, And AI
- **Operational efficiency support** — Support New Operational Efficiencies
- **Business insights** — Generate Business Insights
- **No additional capital investment** — Access Capabilities Without Additional Capital Investment

### [IQVIA Virtual Research](https://www.iqvia.com/solutions/innovative-models/virtual-research)
*Service*
Bring research to patients at home while supporting recruitment, retention, faster study timelines and improved data quality.
IQVIA Virtual Research brings clinical trials and real-world studies to patients at home. The service is designed to boost recruitment and retention, speed timelines and improve data quality.

- **At-home study participation** — Bring Research To Patients
- **Recruitment support** — Boost Study Recruitment
- **Retention support** — Support Participant Retention
- **Study timeline improvement** — Speed Study Timelines
- **Data quality improvement** — Improve Data Quality

### [IQVIA Emerging Biopharma Analytics](https://www.iqvia.com/solutions/industry-segments/emerging-biopharma/emerging-biopharma-analytics)
*Service*
Turns patient claims data into launch insights to help emerging biopharma companies make faster pre-launch decisions and reduce costs.
IQVIA Emerging Biopharma Analytics supports commercial and launch planning with advanced analytics. A featured case study describes using patient claims data to generate actionable launch insights, helping an emerging biopharma company accelerate pre-launch decision-making and reduce costs.

- **Patient claims data analysis** — Turn Claims Data Into Insights
- **Launch decision support** — Accelerate Pre-Launch Decisions
- **Rapid analytics deployment** — Deploy Analytics In Weeks
- **Launch planning cost reduction** — Reduce Launch Planning Costs

## Market Segments

- **Clinical development** (market size $95.0B, CAGR 7.1%): End-to-end clinical trial execution and data management across early‑phase through Phase II–IV, including decentralized/hybrid trials, bioanalytical services, pharmacovigilance, and CDMS implementation to accelerate timelines and improve data quality.
  - Products: Research & Development Solutions, Predictive Clinical Development, IQVIA Virtual Research, IQVIA IRT Supply Automation Value Engine (SAVE), IQVIA Life Science Models, IQVIA.ai
- **Life sciences commercialization** (market size $25.0B, CAGR 8%): Data, analytics and services that help life sciences companies plan product launches, assess markets, establish pricing and access strategies, and improve field execution and healthcare professional engagement.
  - Products: Commercialization solutions, IQVIA Commercial Agentic AI, IQVIA Emerging Biopharma Analytics, IQVIA Emerging Biopharma Commercial Solutions, IQVIA Explorer, IQVIA Field Force Agent, IQVIA Global Market Insights Agent, IQVIA Life Science Models, IQVIA.ai
- **Real-world evidence and HEOR** (market size $5.0B, CAGR 15.8%): Generation, analysis, and integration of real‑world data and health economics and outcomes research to support regulatory submissions, payer evidence, and value demonstration.
  - Products: Real World Evidence solutions, IQVIA Literature AI Platform, IQVIA Life Science Models, IQVIA Virtual Research, IQVIA.ai
- **Pharmacovigilance and regulatory compliance** (market size $18.0B, CAGR 10.5%): Services and platforms that help life sciences organizations manage drug safety, regulatory information, approvals, quality requirements and compliance with engagement and transparency obligations.
  - Products: Safety and regulatory compliance solutions, IQVIA SmartSolve RIM, Real World Evidence solutions
- **Health data privacy** (market size $1.4B, CAGR 8.12%): Platforms that help healthcare and life sciences organizations use sensitive health data for research and analytics while protecting individual privacy.
  - Products: IQVIA Privacy Analytics Platform

## Sources

- [IQVIA](https://iqvia.com)
- [IQVIA Life Science Models](https://www.iqvia.com/solutions/innovative-models/artificial-intelligence-and-machine-learning/life-science-models)
- [Predictive Clinical Development](https://www.iqvia.com/solutions/research-and-development)
- [IQVIA.ai](https://www.iqvia.com/solutions/innovative-models/artificial-intelligence-and-machine-learning/iqvia-ai-platform)
- [IQVIA Field Force Agent](https://www.iqvia.com/solutions/commercialization/commercial-analytics/omnichannel-engagement-and-insights/field-force-agent)
- [IQVIA Global Market Insights Agent](https://www.iqvia.com/)
- [IQVIA Explorer](https://www.iqvia.com/newsroom/2026/10/iqvia-launches-iqvia-explorer-to-help-life-sciences-companies-make-better-commercial-decisions)
- [IQVIA Commercial Agentic AI](https://www.iqvia.com/solutions/commercialization/iqvia-commercial-agentic-ai)
- [IQVIA Literature AI Platform](https://www.iqvia.com/blogs/2026/06/iqvia-literature-ai-platform-for-scientific-literature-reviews)
- [IQVIA Privacy Analytics Platform](https://www.iqvia.com/blogs/2026/06/paving-the-way-for-scalable-data-privacy-and-real-world-impact)
- [IQVIA SmartSolve RIM](https://www.iqvia.com/blogs/2026/04/iqvia-smartsolve-rim-wins-silver-stevie-award-for-healthcare-technology-innovation)
- [IQVIA IRT Supply Automation Value Engine (SAVE)](https://www.iqvia.com/blogs/2026/05/iqvia-irt-save-recognized-with-silver-stevie-award-for-innovation-in-clinical-supply-management)
- [AI-enabled clinical decision support tool for type 1 diabetes](https://www.iqvia.com/newsroom/2026/08/iqvia-ai-enabled-clinical-decision-support-tool-wins-2026-ai-breakthrough-award)
- [IQVIA Emerging Biopharma Commercial Solutions](https://www.iqvia.com/solutions/industry-segments/emerging-biopharma)
- [Real World Evidence solutions](https://www.iqvia.com/solutions/real-world-evidence)
- [Commercialization solutions](https://www.iqvia.com/solutions/commercialization)
- [Safety and regulatory compliance solutions](https://www.iqvia.com/solutions/safety-regulatory-compliance)
- [IQVIA Technologies](https://www.iqvia.com/solutions/technologies)
- [IQVIA Virtual Research](https://www.iqvia.com/solutions/innovative-models/virtual-research)
- [IQVIA Emerging Biopharma Analytics](https://www.iqvia.com/solutions/industry-segments/emerging-biopharma/emerging-biopharma-analytics)
- [The global clinical operations and development market size was valued at USD 89.07 billion in 2024. The market is projected to grow from USD 95.01 billion in 2025 to USD 176.29 billion by 2034, exhibiting a CAGR of 7.1% during 2025–2034.](https://www.polarismarketresearch.com/industry-analysis/clinical-operations-and-development-market)
- [Clinical Trials Market size was valued at USD 99.1 billion in 2026 and is projected to reach USD 198.62 billion by the end of 2036, registering around 7.2% CAGR.](https://www.researchnester.com/reports/clinical-trials-research-market/4215)
- [The life sciences IT market is also expanding, with total spending around $40 billion, of which approximately $12 billion is outsourced.](https://www.indegene.com/what-we-think/reports/global-life-sciences-industry-trends-2025)
- [2025 Market Size $4.15 Billion; CAGR (2025 - 2035) 17.2%.](https://www.marketresearchfuture.com/reports/real-world-evidence-market-21877)
- [The Global Health Economics & Outcomes Research Service Market Size Was Estimated at USD 1.73 Billion in 2025; CAGR of around 13.45%.](https://www.sphericalinsights.com/reports/health-economics-outcomes-research-heor-service-market)
- [The global Real-World Evidence Solutions market is projected to reach USD 4.5 Billion by 2029 from USD 2 billion in 2024, at a CAGR of 16.5%.](https://www.linkedin.com/pulse/global-real-world-evidence-solutions-market-component-4bige)
- [The data privacy software market was valued at USD 4.50 billion in 2025.](https://www.snsinsider.com/reports/data-privacy-software-market-10298)